Gruber Dafna - 18 Mar 2026 Form 3 Insider Report for Cellebrite DI Ltd. (CLBT)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 08:11:04 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dafna Gruber

Key filing fact

Gruber Dafna filed Form 3 for Cellebrite DI Ltd. (CLBT) on 18 Mar 2026.

Key facts

  • This page summarizes Gruber Dafna's Form 3 filing for Cellebrite DI Ltd. (CLBT).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 08:11.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001971695 Primary reporting owner

Gruber Dafna

Relationship
Director
Address
94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL
Signature
/s/ Dafna Gruber
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLBT holding

Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
27,919
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 10,601 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 17, 2025 and vest on September 17, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .